PharmaShots | Incisive News in 3 Shots

Subscribe Now

CervoMed

CervoMed’s Neflamapimod Secures the US FDA’s Orphan Drug Designation to Treat Frontotemporal Dementia

CervoMed’s Neflamapimod Secures the US FDA’s Orphan Drug Designation to Treat Frontotemporal Dementia

November 29, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us